West Pharmaceutical Services WST Proprietary Products — Interest Expense
Discontinued — last reported Q4 '19
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:InterestExpense.
The official record: West Pharmaceutical Services’s 10-K, filed February 24, 2020, on SEC EDGAR. View the filing →
Questions, answered.
- What does proprietary products — interest expense mean?
- The interest costs associated with debt allocated to this business segment.
- How do you interpret proprietary products — interest expense?
- Increasing interest expense relative to segment profit may indicate rising leverage or higher borrowing costs.
- How does proprietary products — interest expense compare across companies?
- Often reported as 'Allocated Interest Expense' in segment reporting for companies with centralized treasury functions.